Amolyt Pharma raised €130m in Series C funding co-led by Sofinnova Partners and Intermediate Capital Group

Health services Pharma

Investments

06 January 2023

Amolyt Pharma (company)

Health services Pharma

Total investments received (USD): N/A

Round value (USD): 139.66m

Round investors: Andera Partners Crédit Agricole EQT Partners Novo A/S OrbiMed Advisors Sofinnova Partners Tekla Capital Management Turenne Capital Partenaires Pontifax Venture Capital Intermediate Capital Group Relyens Group CTI Life Sciences

Industry: Health services Pharma

Automotive Energy Manufacturing

Investments 13 June 2023

Biotech Health services Pharma

Investments 06 June 2023

Health services Manufacturing Pharma

Investments 03 June 2023

Ecommerce Health services

Investments 29 May 2023

AI (big data) Software Services

Investments 14 May 2023